Propanc Biopharma Inc (PPCB)

[elkhunter]

As long as Delafield Investment owns approx. 40 percent of the company's value it will not run until Delafield wants it to run. Expect no real price increase until successful completion of Phase 1 trials. Company needs partnership with another pharmaceutial company to fund continued research and development. PPCH will not generate revenue until at least 2019 if everything goes accourting to schedule. In the mean time it only generates debt.